Search
TScan Therapeutics Inc
TCRXAdd to Watchlist
0.355USD
+0.024+7.25%
Close 09-22 16:00（ET）
23.72MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+7.25%
5 Days
+16.01%
1 Month
-54.49%
6 Months
-65.87%
Year to Date
-64.50%
1 Year
-80.17%
Key Figures
0.333Open
0.360High
34.21KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
0.331Prev. Close
0.337Low
12.03KTurnover
LossP/E Static
0.34P/B
0.00%Div Yield TTM
-46.50%ROA
2.57052wk High
0.04Volume Ratio
-127.50MNet Profit
67.78MShares
-0.9574EPS TTM
0.99Beta
-80.95%ROE
0.29052wk Low
6.95%Amplitude
100.00%Gross Margin
23.72MMarket Cap
-3.20Reward/Risk
6.20%Risk Rate
More news coming soon, stay tuned...
TScan Therapeutics Inc's Score
-0.20vs previous score
Forecast6.57
Financial Health5.52
Technical7.18
Valuation Dimensions9.05
Institutional Confidence5.00
Risk Assessment2.13
Media Coverage
Coverage Level
Very Low
Very High
Negative
Analyst Rating
TScan Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.23/-0.21
Revenue / Forecast
1.05M/1.67M
TScan Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolTCRX
Number of employees194
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Lynx1 Capital Advisors LLC | 13.13% |
| BVF Partners L.P. | 8.56% |
| K2 HealthVentures LLC | 5.90% |
| Baker Bros. Advisors LP | 4.56% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 20.75% |
| Hedge Fund | 18.58% |
| Venture Capital | 8.30% |
| Investment Advisor/Hedge Fund | 6.39% |
Related Instruments
+0.53%
-0.10%
+0.16%
+0.28%
+0.94%
+0.21%
+4.34%
+1.40%
+0.68%
-1.01%
+0.84%
-0.59%
+0.54%
-0.70%
+0.02%
+0.72%
+5.56%
-2.47%
+0.32%
-1.64%Popular Instruments
51878.600
-163.400 (-0.31%)
30708.600
+235.900 (+0.77%)
7762.900
+2.800 (+0.04%)
14638.000
+44.000 (+0.30%)
67056.000
+534.000 (+0.80%)
6347.800
+19.000 (+0.30%)
89.879
-2.077 (-2.26%)
339.750
+0.770 (+0.23%)
228.870
+1.490 (+0.66%)
4358.280
+15.560 (+0.36%)
FAQs
What is the current price of TScan Therapeutics Inc (TCRX)?
The current price of TScan Therapeutics Inc (TCRX) is 0.33.
What is the symbol of TScan Therapeutics Inc?
The ticker symbol of TScan Therapeutics Inc is TCRX.
What is the 52-week high of TScan Therapeutics Inc?
The 52-week high of TScan Therapeutics Inc is 2.57.
What is the 52-week low of TScan Therapeutics Inc?
The 52-week low of TScan Therapeutics Inc is 0.29.
What is the market capitalization of TScan Therapeutics Inc?
The market capitalization of TScan Therapeutics Inc is 22.23M.
Is TScan Therapeutics Inc (TCRX) currently rated as Buy, Hold, or Sell?
According to analysts, TScan Therapeutics Inc (TCRX) has an overall rating of signal_hold, with a price target of 2.67.
What is the Earnings Per Share (EPS TTM) of TScan Therapeutics Inc (TCRX)?
The Earnings Per Share (EPS TTM) of TScan Therapeutics Inc (TCRX) is -0.96.